Chronic Hepatitis B Virus Infection: Biological Parameters in Patients Treated with Tenofovir Disoproxil Fumarate

Sanogo, Sanra Déborah and Dicko, Moussa Y. and N’Diaye, Lamine and Diarra, Ousmane and Katilé, Drissa and Maiga, Abdoulaye and Mallé, Ouatou and Drabo, Sabine and Tounkara, Makan S. and Sow, Hourouma and Doumbia, Kadiatou and Konaté, Anselme and Diarra, Moussa T. (2024) Chronic Hepatitis B Virus Infection: Biological Parameters in Patients Treated with Tenofovir Disoproxil Fumarate. Open Journal of Gastroenterology, 14 (04). pp. 145-151. ISSN 2163-9450

[thumbnail of ojgas2024144_51900896.pdf]

Text
ojgas2024144_51900896.pdf - Published Version
Download (569kB)

Official URL: https://doi.org/10.4236/ojgas.2024.144016

Abstract

Chronic hepatitis B causes a liver disease characterized by inflammation of the liver parenchyma. The aim of this study was to investigate the evolution of biological parameters in patients treated with Tenofovir for chronic B infection at the Commune V referral health center in Bamako. We obtained a prevalence of 14.15%. The most represented age group was 31 - 40 years, with 36.8%. The sex ratio was 1.44 in favour of men. Viral load was undetectable after 18 months of treatment in 25 patients (42.37%). Tenofovir, the 1st-line drug in Mali, is effective on the biological parameters monitored in patients.

Item Type:	Article
Subjects:	Archive Paper Guardians > Multidisciplinary
Depositing User:	Unnamed user with email support@archive.paperguardians.com
Date Deposited:	07 May 2024 10:27
Last Modified:	07 May 2024 10:27
URI:	http://archives.articleproms.com/id/eprint/2798

Actions (login required)

: View Item